Thalidomide-O-amido-C6-NH2
Modify Date: 2025-08-26 17:58:43
Thalidomide-O-amido-C6-NH2 structure
|
Common Name | Thalidomide-O-amido-C6-NH2 | ||
|---|---|---|---|---|
| CAS Number | 1950635-13-8 | Molecular Weight | 430.45 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H26N4O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Thalidomide-O-amido-C6-NH2Thalidomide-O-amido-C6-NH2 (Cereblon Ligand-Linker Conjugates 11), a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker, can be used in the synthesis of PROTACs[1]. |
| Name | Thalidomide-O-amido-C6-NH2 |
|---|
| Description | Thalidomide-O-amido-C6-NH2 (Cereblon Ligand-Linker Conjugates 11), a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker, can be used in the synthesis of PROTACs[1]. |
|---|---|
| Related Catalog | |
| Target |
Cereblon |
| In Vitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. |
| References |
| Molecular Formula | C21H26N4O6 |
|---|---|
| Molecular Weight | 430.45 |
| Hazard Codes | Xi |
|---|